Effect of Rozerem on the Perception of Gastroesophageal Reflux Disease Symptoms in Patients With Chronic Insomnia.
Phase of Trial: Phase III
Latest Information Update: 22 Feb 2017
At a glance
- Drugs Ramelteon (Primary)
- Indications Gastro-oesophageal reflux; Insomnia
- Focus Therapeutic Use
- 11 May 2011 Planned End Date changed from 1 Jun 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 11 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 May 2010 New trial record